Cargando…
Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration
Methylparaben, ethylparaben, and propylparaben are widely used as preservatives in food, cosmetics, and pharmaceutical products. Parabens are also known to bind the estrogen receptor and induce weak estrogen activity in laboratory bioassays. Many OTC topical medications contain one or more parabens...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089598/ http://dx.doi.org/10.1210/jendso/bvab048.995 |
_version_ | 1783687077083217920 |
---|---|
author | Allen, Brianna Ma, Peng Zhang, Changde Wiese, Thomas E |
author_facet | Allen, Brianna Ma, Peng Zhang, Changde Wiese, Thomas E |
author_sort | Allen, Brianna |
collection | PubMed |
description | Methylparaben, ethylparaben, and propylparaben are widely used as preservatives in food, cosmetics, and pharmaceutical products. Parabens are also known to bind the estrogen receptor and induce weak estrogen activity in laboratory bioassays. Many OTC topical medications contain one or more parabens as preservative ingredients. In this study, we surveyed the estrogen activity of extracts from OTC topical medications and tested the hypothesis that a combined threshold concentration of particular parabens is required to induce estrogen activity in human breast cancer cell bioassays. Ethanol extracts (1 gm:1 ml) were prepared from OTC topical medications containing parabens (including: Olay Quench Lotion, CeraVe Daily Moisturizing Lotion and Cortizon-10 Lotion). The estrogen agonist and antagonist activity of each extract was determined using the T47dkbluc estrogen reporter gene and the MCF-7 E3 estrogen responsive proliferation assays. The extracts from Olay Quench Lotion and CeraVe Daily Moisturizing Lotion induced estrogen agonist activity in the MCF-7 proliferation assay. The extract from the Cortizon-10 Lotion did not induce significant estrogen activity. The product ingredients of each OTC topical medications tested listed ethyl and propyl parabens while the Olay Quench Lotion also contained the least estrogenic paraben methylparaben. We propose that the estrogenic potential of OTC topical medications can be estimated with LC-MS analysis determination of paraben content and concentration. This study illustrates that measurable estrogen activity from OTC topical medications requires the presence of estrogenic parabens (ethyl and propyl) at total concentrations that exceed a threshold. Thus, estrogen activity depends on the type and concentration of paraben present in the OTC topical products. While the capacity for these OTC topical medications to induce estrogen activity in individuals using the products is unclear, consumers may benefit from more information about the paraben type and concentration present. |
format | Online Article Text |
id | pubmed-8089598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-80895982021-05-06 Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration Allen, Brianna Ma, Peng Zhang, Changde Wiese, Thomas E J Endocr Soc Endocrine Disruption Methylparaben, ethylparaben, and propylparaben are widely used as preservatives in food, cosmetics, and pharmaceutical products. Parabens are also known to bind the estrogen receptor and induce weak estrogen activity in laboratory bioassays. Many OTC topical medications contain one or more parabens as preservative ingredients. In this study, we surveyed the estrogen activity of extracts from OTC topical medications and tested the hypothesis that a combined threshold concentration of particular parabens is required to induce estrogen activity in human breast cancer cell bioassays. Ethanol extracts (1 gm:1 ml) were prepared from OTC topical medications containing parabens (including: Olay Quench Lotion, CeraVe Daily Moisturizing Lotion and Cortizon-10 Lotion). The estrogen agonist and antagonist activity of each extract was determined using the T47dkbluc estrogen reporter gene and the MCF-7 E3 estrogen responsive proliferation assays. The extracts from Olay Quench Lotion and CeraVe Daily Moisturizing Lotion induced estrogen agonist activity in the MCF-7 proliferation assay. The extract from the Cortizon-10 Lotion did not induce significant estrogen activity. The product ingredients of each OTC topical medications tested listed ethyl and propyl parabens while the Olay Quench Lotion also contained the least estrogenic paraben methylparaben. We propose that the estrogenic potential of OTC topical medications can be estimated with LC-MS analysis determination of paraben content and concentration. This study illustrates that measurable estrogen activity from OTC topical medications requires the presence of estrogenic parabens (ethyl and propyl) at total concentrations that exceed a threshold. Thus, estrogen activity depends on the type and concentration of paraben present in the OTC topical products. While the capacity for these OTC topical medications to induce estrogen activity in individuals using the products is unclear, consumers may benefit from more information about the paraben type and concentration present. Oxford University Press 2021-05-03 /pmc/articles/PMC8089598/ http://dx.doi.org/10.1210/jendso/bvab048.995 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Endocrine Disruption Allen, Brianna Ma, Peng Zhang, Changde Wiese, Thomas E Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration |
title | Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration |
title_full | Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration |
title_fullStr | Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration |
title_full_unstemmed | Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration |
title_short | Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration |
title_sort | estrogen activity of otc topical medications containing parabens depends on paraben type and concentration |
topic | Endocrine Disruption |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089598/ http://dx.doi.org/10.1210/jendso/bvab048.995 |
work_keys_str_mv | AT allenbrianna estrogenactivityofotctopicalmedicationscontainingparabensdependsonparabentypeandconcentration AT mapeng estrogenactivityofotctopicalmedicationscontainingparabensdependsonparabentypeandconcentration AT zhangchangde estrogenactivityofotctopicalmedicationscontainingparabensdependsonparabentypeandconcentration AT wiesethomase estrogenactivityofotctopicalmedicationscontainingparabensdependsonparabentypeandconcentration |